Researchers at the University of California, San Francisco found that habitual cannabis users experienced fewer premature heartbeats on days they inhaled cannabis compared to days they abstained, according to findings published August 12.
The study tracked participants over time and measured premature ventricular contractions—irregular heartbeats originating in the heart's lower chambers. Users showed approximately 9% fewer of these irregular beats on days they smoked or vaped cannabis versus days without use.
"We went into this expecting to find the opposite," said Dr. Gregory Marcus, a cardiologist at UCSF who led the research. The team originally hypothesized that cannabis use would increase cardiac irregularities based on prior assumptions about the drug's cardiovascular effects.
The Research Design
The UCSF team recruited habitual cannabis users and monitored their heart rhythms using portable ECG devices while participants logged their daily cannabis consumption. This real-world tracking approach differs from controlled laboratory settings and captures actual usage patterns.
Premature heartbeats are common and usually harmless, but frequent occurrences can indicate underlying cardiac issues or increase stroke risk in some patients. The medical community has long debated cannabis's cardiovascular effects, with most research focusing on acute impacts like temporary heart rate increases.
The 9% reduction appeared specifically on inhalation days. The study did not examine edibles or other consumption methods, which produce different cannabinoid absorption profiles and may yield different cardiac effects.
Industry and Medical Implications
The findings arrive as the cannabis industry faces ongoing scrutiny over health claims. Federal prohibition has limited large-scale cardiac research, leaving physicians with incomplete data when counseling patients about cannabis use and heart conditions.
"This adds another data point, but we need much larger studies," Marcus noted. The research does not suggest cannabis as a cardiac treatment, and the team cautioned against over-interpreting preliminary results.
Several state medical marijuana programs already list certain cardiac conditions as qualifying diagnoses, though evidence remains mixed. The American Heart Association has maintained that insufficient research exists to recommend cannabis for cardiovascular health.
What Researchers Say Next
The UCSF team plans expanded studies examining different consumption methods, dosing levels, and longer-term cardiac outcomes. They're also investigating whether specific cannabinoids or terpenes drive the observed effects.
Marcus emphasized that the current findings should not change medical advice around cannabis and heart health. Patients with cardiac conditions should consult physicians before using cannabis, particularly given its known effects on blood pressure and heart rate during acute intoxication.
The research received funding from the National Institutes of Health and was published in a peer-reviewed cardiology journal. Full methodology and participant demographics are available in the published paper.
As federal rescheduling discussions continue, studies like this one highlight the research gaps that decades of prohibition created. The medical community awaits larger-scale trials that could definitively characterize cannabis's cardiovascular profile.
This article is based on original reporting by ganjapreneur.com.
